Sharon Fenick
62 IP cases indexed. Covers patent matters.
Cases Presided Over
62 cases indexed | Page 1 of 3
Samsung Electronics Co., Ltd. et al. v.Hannibal IP LLC
Samsung Electronics and Hannibal IP entered a settlement that led to the joint termination of IPR2025-01189 concerning patent 11,368,911. The Board granted the motion and kept the settlement agreement confidential.
WHOOP, Inc. v.Omni MedSci, Inc.
In a Final Written Decision, the PTAB held that WHOOP proved 12 of the 23 challenged claims of Omni MedSci’s wearable physiological‑monitoring patent unpatentable, while the remaining claims were left intact.
WHOOP, Inc. v.Omni MedSci, Inc.
Apple’s IPR against Omni MedSci’s wearable physiological monitoring patent resulted in the Board finding all challenged claims unpatentable as obvious over Lisogurski, Carlson, and Mannheimer references.
WHOOP, Inc. v.Omni MedSci, Inc.
The PTAB, on remand, affirmed that all 23 claims of Omni MedSci’s wearable pulse‑oximeter patent are unpatentable. The Board relied on obviousness over a combination of prior‑art references and upheld the claim construction of “identify an object.”
WHOOP, Inc. v.Omni MedSci, Inc.
The PTAB held that WHOOP proved unpatentability of 12 of the 23 claims of Omni MedSci’s wearable physiological‑measurement patent, while the remaining 11 claims were left intact. The decision hinged on obviousness over a combination of prior‑art references covering optical sensing, modulation, and AI‑driven analysis.
WHOOP, Inc. v.Omni MedSci, Inc.
The PTAB held that WHOOP’s challenge succeeded, finding all of the asserted claims of Omni MedSci’s ‘533 patent unpatentable as obvious over Lisogurski, Carlson, and Mannheimer prior art.
WHOOP, Inc. v.Omni MedSci, Inc.
Apple’s IPR against WHOOP resulted in the Board finding all 23 claims of the wearable health‑monitoring patent unpatentable under obviousness. The decision affirmed the petitioner’s claim construction and rejected the patent owner’s arguments.
Samsung Electronics Co., Ltd. et al. v.Hannibal IP LLC
Samsung and Hannibal IP entered a settlement that led to the joint termination of IPR2025-01187 concerning U.S. Patent 11,057,896. The Board granted the motion and ordered the settlement agreement to be kept confidential.
Google LLC v.Valtrus Innovations Limited et al.
The PTAB held that Google’s challenge to Valtrus’s 7,748,005 patent succeeded, finding all twenty claims unpatentable for lack of written‑description support and obviousness over the McCarthy application and Gien micro‑kernel reference.
Google LLC v.Valtrus Innovations Limited et al.
The PTAB held that Google proved all 21 claims of Valtrus’s ’454 patent are obvious over Colby, Eilert, and Jindal, rendering the entire patent unpatentable.
Google LLC v.Valtrus Innovations Limited et al.
Google’s IPR against Valtrus’s 6,728,704 B2 patent was decided with all 23 challenged claims upheld. The Board found the prior‑art Bushee not anticipatory and rejected obviousness arguments over Voorhees, Tso, and Koppel.
Google LLC v.Valtrus Innovations Limited et al.
The PTAB held that Google’s obviousness challenge succeeded, finding all 19 claims of Valtrus’s ’764 patent unpatentable over the Li and Edlund prior‑art references. The decision also denied Google’s motion to exclude exhibits and granted motions to seal.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
The PTAB held that Apple’s wearable physiological measurement claims were obvious over prior‑art pulse‑oximetry references, rendering all challenged claims unpatentable. The decision relied on Lisogurski, Carlson, and Mannheimer teachings.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
The PTAB issued a Final Written Decision in IPR2021‑00453, finding claims 1,2,7 and 15‑23 of Omni MedSci’s wearable pulse‑oximeter patent unpatentable over prior art, while leaving the remaining claims intact.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple (as petitioner) secured a Final Written Decision finding claims 1,2,7,15‑23 of Omni MedSci’s wearable health‑monitoring patent unpatentable as obvious over prior‑art. The Board affirmed the petitioner's obviousness arguments while leaving claims 3‑6 and 8‑14 intact.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
The PTAB issued a Final Written Decision on remand, holding that all 23 claims of Omni MedSci’s wearable pulse‑oximeter patent are unpatentable. The Board relied on an obviousness analysis over a combination of prior‑art references and affirmed the claim construction of “identify an object.”
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
The PTAB issued a Final Written Decision on Remand, finding all 23 claims of Omni MedSci’s wearable pulse‑oximeter patent unpatentable. Apple’s arguments on obviousness over multiple prior‑art references prevailed.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
The PTAB held that Samsung’s challenge to Omni MedSci’s wearable physiological monitoring patent succeeded on 12 of the 23 claims, finding them obvious over prior‑art references such as Lisogurski, Carlson, Tran, Isaacson and Valencell‑093. The remaining claims were not shown unpatentable.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s IPR against Omni MedSci’s ‘533 patent resulted in all challenged claims being found unpatentable. The Board held that the claims were obvious over prior‑art references Lisogurski, Carlson, and Mannheimer.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s wearable physiological‑monitoring patent was declared entirely unpatentable after Samsung’s PTAB challenge, with the Board finding the claims obvious over a combination of prior‑art references covering optical sensors, pulse‑rate modulation, spaced emitters, and reflective surfaces.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple prevailed in IPR2020‑00175, with the PTAB finding all six challenged claims of the ’299 patent unpatentable as obvious over Lisogurski, Carlson, Mannheimer and Park references.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple prevailed in an IPR against Omni MedSci’s wearable health‑monitoring patent, finding 12 of the 23 claims unpatentable while the remaining claims survived.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple (as petitioner) prevailed in an IPR against Omni MedSci’s 9,651,533 patent, with the PTAB finding all challenged claims unpatentable as obvious over Lisogurski, Carlson, and Mannheimer. The decision hinges on pulse‑rate and signal‑to‑noise teachings in the prior art.
LG ELECTRONICS, INC. et al. v.Multimedia Technologies Pte. Ltd.
VIZIO successfully convinced the PTAB that MULTIMEDIA TECHNOLOGIES PTE. LTD.'s claims related to VOD user interfaces were obvious over prior art references. The Board found that combining existing concepts from sources like TechnoBuffalo and Kim provided sufficient motivation for a Person Having Ordinary Skill in the Art (POSITA).
Samsung Electronics Co., Ltd. et al. v.Empire Technology Development LLC
Samsung Electronics successfully petitioned for IPR against Empire Technology Development's patent, arguing that the claims are obvious over prior art. The Board preliminarily adopted a broad definition of 'idle power consumption,' setting the stage for a detailed examination of technical combination possibilities.
Samsung Electronics Co., Ltd. et al. v.Empire Technology Development LLC
The PTAB found claims 25-28 unpatentable over Li and Siam, based on obviousness (103). The Board adopted a specific construction of 'idle power consumption' as power consumed while powered on and waiting to send data. However, the attempt to prove obviousness for claim 29 failed due to impermissible hindsight bias.
Roku, Inc. v.Dolby International AB
Roku, Inc.'s IPR challenge against Dolby International AB's audio signal coding patents was denied by the PTAB. The Board found that Roku failed to establish a reasonable likelihood of prevailing on any obviousness grounds (35 U.S.C. § 103).
Genius Sports Ltd. v.SportsCastr Inc.
The PTAB institution decision was granted, finding sufficient rationale for the Petitioner to combine teachings from prior art references (Ellis and Spivey) under 35 U.S.C. § 103. The Board specifically found that combining Ellis's content source with Spivey’s live data server devices would improve latency in real-time event delivery.
Genius Sports Ltd. v.SportsCastr Inc.
Genius Sports Ltd. successfully convinced the PTAB to institute IPR proceedings against SportsCastr Inc. d/b/a PANDA Interactive regarding live event broadcasting claims. The Board accepted the Petitioner's arguments that the claimed technology is obvious over combinations of prior art references, including Ellis and Spivey. This sets the stage for a full trial on unpatentability grounds.
Genius Sports Ltd. v.SportsCastr Inc.
The PTAB institution decision found reasonable likelihood of unpatentability for Genius Sports Ltd.'s claims against SportsCastr Inc. The Board determined that the combination of prior art references (Ellis, Spivey, Herzog) taught or suggested all limitations of Claim 1 and its dependents based on the preliminary record. This sets a significant hurdle for SportsCastr's patent validity in digital media streaming technology.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.